Aethlon medical announces third quarter financial results and provides corporate update

San diego, feb. 14, 2022 /prnewswire/ -- aethlon medical, inc. (nasdaq: aemd), a company developing medical technology to treat cancer and life-threatening infectious diseases, today reported financial results for its third quarter ended december 31, 2021 and provided an update on recent developments.  company updates aethlon medical is continuing the research and clinical development of the hemopurifier™, our therapeutic blood filtration system that can bind and remove life-threatening viruses and harmful exosomes from blood.
AEMD Ratings Summary
AEMD Quant Ranking